Thomson Medical Singapore has partnered with OncoCare to launch the Thomson OncoCare Cancer Centre, a new facility at Thomson Medical Centre, to provide advanced cancer care. This collaboration marks a significant expansion in Thomson Medical’s strategy to offer comprehensive, family-focused healthcare services. The centre will be led by four senior oncologists, offering personalised treatment for various cancers, including rare types.
The partnership reflects Thomson Medical’s commitment to integrating specialist care across its services, traditionally known for women’s health, obstetrics, and paediatrics. The new centre will provide a full spectrum of cancer care services, including medical oncology consultations, chemotherapy, and genetic counselling. Patients will benefit from a multidisciplinary approach, ensuring a supportive environment for families.
Dr Melvin Heng, Group CEO of Thomson Medical Group, emphasised the collaborative nature of modern healthcare, stating, “This is what the future of healthcare looks like—collaborative, connected, and patient-centric.” The partnership with OncoCare, which also extends to Malaysia, aims to bridge gaps in early detection and treatment, addressing the growing cancer concerns in Singapore.
The centre is set to open to patients in July 2025, with plans to enhance services and explore digital solutions for improved patient care. This initiative is part of Thomson Medical’s broader strategy to expand its specialties, ensuring patients receive world-class care under one roof. The collaboration with OncoCare is expected to elevate the standard of cancer care in the region, making it more accessible and coordinated.
“`
